secwatch.observer — SEC 8-K summary
======================================

Issuer:     BiomX Inc. (PHGE)
CIK:        0001739174
Form:       8-K
Filed at:   2026-09-29T13:20:17+00:00
Accession:  0001213900-26-104363
Event type: other_material
Sentiment:  positive
Materiality: 0.60
Item codes: 7.01, 9.01
LLM model:  deepseek-v4.1-flash:cloud@v2

Tessera targets 2027 revenue of $14-16M and ~$30M by 2029, implying ~40% CAGR
-----------------------------------------------------------------------------

- Initial 2027 revenue target of $14M-$16M, weighted to H2 2026 platform deployments; 2028 target ~$21M and 2029 target ~$30M.
- 2027 target build: $7M from backlog/signed contracts/purchase orders, $5M from existing-customer expansion, $3M from new customers.
- 2027 milestones: 70 platform deployments, 60 new customers, 15 expansion projects, 3 new geographies, 2 new verticals, 16 integrator/channel relationships.
- Targets ~$7-8M (50% of 2027 revenue) from recurring software, licensing, service and support; ~$14M backlog expected by year-end 2027.
- Growth plan combines organic expansion of the Tessera platform (Zorronet, DFSL subsidiaries) with selective future acquisitions; excludes companies under unexercised acquisition options.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1739174/000121390026104363/0001213900-26-104363-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1739174/000121390026104363/ea0306991-8k_tessera.htm
  HTML page:      https://secwatch.observer/filing/0001213900-26-104363

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer